{
    "eid": "2-s2.0-85097754956",
    "title": "The Expression of Proteins Related to Serotonin Pathway in Pulmonary Arteries of Dogs Affected With Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease",
    "cover-date": "2020-12-03",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Veterinary (all)",
            "@code": "3400",
            "@abbrev": "VETE"
        }
    ],
    "keywords": [
        "degenerative mitral valve disease",
        "hyperplasia",
        "pulmonary artery",
        "pulmonary hypertension",
        "serotonin",
        "smooth muscle cells"
    ],
    "authors": [
        "Siriwan Sakarin",
        "Sirilak Disatian Surachetpong",
        "Anudep Rungsipipat"
    ],
    "citedby-count": 3,
    "ref-count": 71,
    "ref-list": [
        "Pulmonary hypertension in dogs: diagnosis and therapy",
        "Historical review, epidemiology and natural history of degenerative mitral valve disease",
        "Pulmonary hypertension in canine degenerative mitral valve disease",
        "ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs",
        "Pulmonary hypertension in dogs with mitral regurgitation attributable to myxomatous valve disease",
        "ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs",
        "Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management",
        "Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure",
        "Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension",
        "Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in \u201cout-of-proportion\u201d pulmonary hypertension",
        "Pathology and pathobiology of pulmonary hypertension",
        "Systemic and pulmonary vascular remodelling in chronic obstructive pulmonary disease",
        "Fluoxetine protects against monocrotaline-induced pulmonary arterial hypertension: potential roles of induction of apoptosis and upregulation of Kv1.5 channels in rats",
        "Fluoxetine inhibits monocrotaline-induced pulmonary arterial remodeling involved in inhibition of RhoA-Rho kinase and Akt signalling pathways in rats",
        "Fluoxetine attenuates chronic methamphetamine-induced pulmonary arterial remodelling: possible involvement of serotonin transporter and serotonin 1B receptor",
        "4-Chloro-DL-phenylalanine protects against monocrotaline induced pulmonary vascular remodeling and lung inflammation",
        "Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats",
        "Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension",
        "The serotonin pathway in pulmonary hypertension",
        "Pulmonary hypertension: therapeutic targets within the serotonin system",
        "Serotonin signaling in pulmonary hypertension",
        "The serotonin hypothesis of pulmonary hypertension revisited",
        "Serotonin and pulmonary hypertension\u2013from bench to bedside?",
        "Pulmonary hypertension and the serotonin hypothesis: where are we now?",
        "Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension",
        "Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene",
        "Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation",
        "Tryptophan hydroxylase 1 expression is increased in phenotype-altered canine and human degenerative myxomatous mitral valves",
        "Prevalence and prognostic importance of pulmonary hypertension in dogs with myxomatous mitral valve disease",
        "Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer",
        "Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease",
        "Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial tph1 attenuates hypoxia-induced pulmonary hypertension",
        "Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene",
        "Pulmonary hypertension with left-sided heart disease",
        "Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats",
        "Effects of renal denervation on monocrotaline induced pulmonary remodeling",
        "Venous and arterial changes in pulmonary veno-occlusive disease, mitral stenosis and fibrosing mediastinitis",
        "Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension?",
        "The pulmonary circulation in heart failure",
        "Insights into serotonin signaling mechanisms associated with canine degenerative mitral valve disease",
        "Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs",
        "Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease",
        "Plasma and platelet serotonin concentrations in healthy dogs and dogs with myxomatous mitral valve disease",
        "Evaluation of chemokines CXCL8 and CCL2, serotonin, and vascular endothelial growth factor serum concentrations in healthy dogs from seven breeds with variable predisposition for canine idiopathic pulmonary fibrosis",
        "Serotonin receptors and heart valve disease\u2013it was meant 2B",
        "Serotonin and catecholamines in the development and progression of heart valve diseases",
        "Milrinone attenuates serotonin-induced pulmonary hypertension and bronchoconstriction in dogs",
        "Spasmolytic effects of prostaglandin E1 on serotonin-induced bronchoconstriction and pulmonary hypertension in dogs",
        "A comparison of the spasmolytic effects of olprinone and aminophylline on serotonin-induced pulmonary hypertension and bronchoconstriction with or without beta-blockade in dogs",
        "Spasmolytic effect of magnesium sulfate on serotonin-induced pulmonary hypertension and bronchoconstriction in dogs",
        "Spasmolytic effects of colforsin daropate on serotonin-induced pulmonary hypertension and bronchoconstriction in dogs",
        "Cardiopulmonary parameters in propofol- or thiopental-anesthetized dogs induced to pulmonary hypertension by serotonin",
        "Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia",
        "Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension",
        "Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats",
        "Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension",
        "Contribution of the 5-HT1B receptor to hypoxia-induced pulmonary hypertension",
        "5-HT1B receptor augmented 5-HT vasoconstrictor response of pulmonary artery in monocrotaline-induced pulmonary hypertensive rats",
        "Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension",
        "Expression of the serotonin 1b receptor in experimental pulmonary hypertension",
        "Proliferation and signaling in fibroblasts: role of 5-hydroxytryptamine2A receptor and transporter",
        "Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease",
        "Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries",
        "Serotonin inhibits voltage-gated K+ currents in pulmonary artery smooth muscle cells: role of 5-HT2A receptors, caveolin-1, and KV1.5 channel internalization",
        "Serotonin aggravates exercise-induced cardiac ischemia in the dog: effect of serotonin receptor antagonists",
        "Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension",
        "Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension",
        "In vivo effects of a combined 5-HT1B receptor/SERT antagonist in experimental pulmonary hypertension",
        "Serotonin passes through myoendothelial gap junctions to promote pulmonary arterial smooth muscle cell differentiation",
        "Protein kinase C\u03b1 stimulates hypoxia-induced pulmonary artery smooth muscle cell proliferation in rats through activating the extracellular signal-regulated kinase 1/2 pathway",
        "Serotonin transmembrane transporter is down-regulated in late-stage canine degenerative mitral valve disease"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Chulalongkorn University",
        "Faculty of Veterinary Science, Chulalongkorn University"
    ]
}